Inactive Instrument

News Avivagen Inc Toronto S.E.

Equities

VIV

CA05382F1036

Summary

Unlock all the news: Be the first to know and act before the market!

Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	Apr. 24	NE
Canadian Investment Regulatory Organization Trading Halt - VIV	Mar. 06	AQ
Avivagen Inc. Announces New 500 Kg Order for OxC-beta	23-10-17	CI
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-28	CI
Avivagen Brief: Announcing several corporate updates, relating to allowances of patents, a waiver of an interest payment on its senior secured debentures and continuation of the strategic review process	23-07-31	MT
Avivagen Secures New Orders for 1.1 Tons of Oxc-Beta Livestock Product	23-07-24	MT
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product	23-07-24	CI
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-06	CI
Avivagen Announces Significant Increase in Sales to an Existing Customer	23-05-26	AQ
Avivagen Reports Increase in Sales to Existing Customer	23-05-25	MT
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer	23-05-25	CI
Avivagen Brief: Announcing "Significant" Increase in Sales to an Existing Customer	23-05-25	MT
Avivagen Launches Strategic Review; Comes After Soaring 50% Yesterday	23-05-18	MT
Avivagen Brief: Announcing Review of Strategic Alternatives	23-05-18	MT
Avivagen Announces Review of Strategic Alternatives	23-05-17	CI
Avivagen Inc. Announces Board Changes	23-04-19	CI
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern	23-03-17	MT
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-03-16	CI
Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth	23-02-22	AQ
Avivagen Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	23-02-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Avivagen Inc Toronto S.E.

Equities

VIV

CA05382F1036

Summary

Filters